Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03858530 · ClinicalTrials.gov registry record · NA
Ultrasound Elastography to Predict Development of SOS
A NA study, sponsored by Children's Mercy Hospital Kansas City.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03858530 is a NA study that was terminated before completion, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 21 participants.
The verdict
NCT03858530, a NA study, was terminated before completion, sponsored by Children's Mercy Hospital Kansas City.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The long-term goal of our research is to accurately identify SOS patients who would benefit from defibrotide treatment using US SWE. The overall objective of this study is to validate SWE as an early diagnostic marker for SOS. Our central hypothesis is that SWE changes will precede clinical and conventional US diagnostic criteria for SOS. Our hypothesis has been formulated on the basis of our own preliminary data. The investigators completed the first prospective cohort trial demonstrating that US SWE provides SOS diagnosis (80% sensitivity and 67% specificity) nine days earlier than current clinical criteria. SWE is widely available, has no known side effects, and is easy to learn and interpret. Our study enrolled 25 high-risk BMT patients over 18 months (five with SOS and two with severe SOS). More data is needed to determine the optimal window for testing to balance between improved test characteristics and early detection of disease. The investigators propose conducting a prospective cohort study with 80 additional patients, 12 of which will likely develop SOS (including four with severe SOS) to optimize SWE timing. This study will increase the confidence in the findings from our preliminary study and allow us to test SWE against newly published clinical criteria. The rationale for the proposed research is that, if SWE can diagnose SOS earlier than clinical criteria, then SWE can guide early initiation of SOS treatment.
Interventions
- DIAGNOSTIC_TEST Ultrasound Examination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2024-01-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03858530
The ClinicalTrials.gov registry entry for NCT03858530 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound Examination is the first listed.
NCT03858530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03858530 about?
NCT03858530 is a clinical study titled "Ultrasound Elastography to Predict Development of SOS". The long-term goal of our research is to accurately identify SOS patients who would benefit from defibrotide treatment using US SWE. The overall objective of this study is to validate SWE as an early diagnostic marker for SOS. Our central hypothesis is that SWE changes will precede clinical and conv...
What is the current status of trial NCT03858530?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2018-05-01. Estimated completion is 2024-01-16.
What interventions are being tested in trial NCT03858530?
The interventions under investigation include: Ultrasound Examination (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03858530?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.